| scholarly article | Q13442814 |
| P2093 | author name string | A John Barrett | |
| Bipin N Savani | |||
| Pamela Stratton | |||
| Stacey Goodman | |||
| Aarthi Shenoy | |||
| Eleftheria Kozanas | |||
| P2860 | cites work | Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review | Q22306450 |
| Case-control study of human papillomavirus and oropharyngeal cancer | Q28301695 | ||
| Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
| Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients | Q33967314 | ||
| Abnormal cervical cytology in bone marrow transplant recipients. | Q34380742 | ||
| Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals | Q34995733 | ||
| Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. | Q35745142 | ||
| Human papillomavirus infection and disease in the HIV+ individual. | Q36900309 | ||
| Human papillomaviruses in transplant-associated skin cancers | Q42459635 | ||
| Giant anal condylomatosis after allogeneic bone marrow transplantation: a rare complication of human papilloma virus infection | Q44490260 | ||
| Multiple neoplastic lesions of the lower genital tract in a human papilloma virus-infected kidney-pancreas allograft recipient: a case report. | Q44779481 | ||
| Cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant recipients. | Q45729095 | ||
| Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. | Q45748817 | ||
| Solid cancers after bone marrow transplantation | Q47582581 | ||
| Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation. | Q51729506 | ||
| Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. | Q51988742 | ||
| Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women | Q61672044 | ||
| Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group | Q73217522 | ||
| Human papillomavirus infection and anogenital condyloma in bone marrow transplant recipients | Q73519572 | ||
| Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry | Q77941016 | ||
| Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation | Q80193284 | ||
| Immune factors involved in the cervical immune response in the HIV/HPV co-infection | Q80274146 | ||
| Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants | Q80496252 | ||
| P433 | issue | 9 | |
| P921 | main subject | dysplasia of cervix | Q19001141 |
| stem cell transplantation | Q65592366 | ||
| P304 | page(s) | 1072-1075 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination | |
| P478 | volume | 14 |
| Q28088322 | Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers |
| Q37285453 | Can routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation? |
| Q38262917 | Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD. |
| Q38772931 | Clinical management of genital chronic GvHD. |
| Q35875607 | Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution. |
| Q38060559 | Clinical practice implications of immunizations after pediatric bone marrow transplant: a literature review |
| Q33822026 | Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups. |
| Q34711338 | Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors |
| Q33965200 | Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies |
| Q91820312 | Female genital tract chronic graft-versus-host disease: A narrative review |
| Q35671371 | Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management |
| Q37347871 | Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation. |
| Q40600058 | Guidelines for vaccination of immunocompromised individuals |
| Q46355059 | HPV vaccination of immunocompromised hosts |
| Q34707208 | How I treat late effects in adults after allogeneic stem cell transplantation |
| Q45323659 | Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia |
| Q34741675 | Human papillomavirus reactivation following treatment of genital graft-versus-host disease |
| Q37547649 | Immunosuppression facilitates the reactivation of latent papillomavirus infections |
| Q33574136 | Late effects of blood and marrow transplantation |
| Q37593798 | Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events. |
| Q64259900 | Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016 |
| Q64045740 | Novel management of vaginal chronic graft-versus-host disease causing haematometra and haematocolpos |
| Q96304256 | Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach |
| Q28079998 | Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update |
| Q38628809 | Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies. |
| Q47441540 | Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study |
| Q50104242 | Second Malignancies after Hematopoietic Stem Cell Transplantation |
| Q37880254 | Secondary cancers following allogeneic haematopoietic cell transplantation in adults |
| Q85203904 | Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced |
| Q28088369 | Secondary solid cancer screening following hematopoietic cell transplantation |
| Q36540467 | The biology of papillomavirus latency |
| Q93274226 | The management of gynecological complications in long-term survivors after allogeneic hematopoietic cell transplantation-a single-center real-life experience |
| Q37113925 | Time to consider HPV vaccination after allogeneic stem cell transplantation |
| Q35161630 | Tumor necrosis factor blockade and the risk of viral infection |
| Q37846281 | Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. |
| Q91465246 | Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) |
Search more.